High-sensitivity cardiac troponin I and T yielded higher diagnostic accuracy for acute myocardial infarction (AUC 0.96 and 0.85) than myoglobin (AUC 0.82) and CK-MB (AUC 0.73).
Do high-sensitivity cardiac troponins outperform myoglobin and CK-MB in the diagnosis of acute myocardial infarction?
High-sensitivity cardiac troponins provide superior diagnostic accuracy and early predictive values compared to traditional biomarkers like CK-MB and myoglobin for suspected acute myocardial infarction.
The concept that high-sensitivity cardiac troponin immunoassays outperform creatine kinase MB (CK-MB) and myoglobin in the diagnostics of acute coronary syndrome has been put forward more than 10 years ago, and is now virtually incontestable. In the seminal study of Keller et al . (1), cardiac troponins, myoglobin and CK-MB were measured in over 1,800 consecutive patients admitted with suspected acute myocardial infarction. In all patients, the diagnostic performance (area under the curve, AUC) of both high-sensitivity cardiac troponin I (cTnI) (AUC, 0.96) and high-sensitivity cardiac troponin T (AUC, 0.85) was found to higher than that of both myoglobin (AUC, 0.82) and CK-MB (AUC, 0.73). Even more importantly, the early (i.e., <3 hours after onset of chest pain) negative and positive predictive values were also higher for high-sensitivity cTnI (0.94 and 0.82, respectively) than for myoglobin (0.87 and 0.64, respectively).
Lippi et al. (Fri,) conducted a editorial in Suspected acute myocardial infarction (n=1,800). High-sensitivity cardiac troponin I and T vs. Myoglobin and CK-MB was evaluated on Diagnostic performance (area under the curve, AUC). High-sensitivity cardiac troponin I and T yielded higher diagnostic accuracy for acute myocardial infarction (AUC 0.96 and 0.85) than myoglobin (AUC 0.82) and CK-MB (AUC 0.73).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: